APPLICATION OF HYDRONIDONE IN PREPARATION OF DRUG FOR TREATING OR PREVENTING CHRONIC HEPATITIS B WITH LIVER FIBROSIS
The present invention provides a use of a compound represented by formula (I) and a solvate, hydrate, prodrug or pharmaceutically acceptable salt thereof in the preparation of a drug for treating or preventing chronic hepatitis B with liver fibrosis. Clinical research proves that the compound may ef...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
04.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a use of a compound represented by formula (I) and a solvate, hydrate, prodrug or pharmaceutically acceptable salt thereof in the preparation of a drug for treating or preventing chronic hepatitis B with liver fibrosis. Clinical research proves that the compound may effectively reverse liver fibrosis, and in particular has a better effect on treating fibrosis in a portal region, significant fibrosis, liver fibrosis in a progressive stage or liver cirrhosis. |
---|---|
Bibliography: | Application Number: AU20220275085 |